Mode
Text Size
Log in / Sign up
N/A N=98 Randomized Single-blind Supportive Care

Development & Testing of a Decision Aid for LVAD Placement

End-Stage Heart Failure · Bridge-to-Transplant LVAD Placement (BTT) · Destination Therapy LVAD Placement (DT) · Refusal of LVAD Placement (Decliners) · LVAD Caregivers

Enrolled (actual)
98
Serious AEs
0.0%
Results posted
May 2019
Primary outcome: Primary: Left Ventricular Assist Device (LVAD) Knowledge Scale — 45.6; 43.8 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
LVAD Decision Aid (Other)
Age
Adult, Older Adult · 30+ yrs
Sex
All
Sponsor
Baylor College of Medicine
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Left Ventricular Assist Device (LVAD) Knowledge Scale
27.9; 22.9 0.47
PRIMARY
Left Ventricular Assist Device (LVAD) Knowledge Scale
27.9; 22.9 0.47
PRIMARY
Left Ventricular Assist Device (LVAD) Knowledge Scale
27.9; 22.9 0.47
SECONDARY
Decisional Conflict Scale
15.7; 17.4 0.79
SECONDARY
Decisional Conflict Scale
15.7; 17.4 0.79
SECONDARY
collaboRATE-Shared Decision Making
90.4; 89.8 0.94
SECONDARY
collaboRATE-Shared Decision Making
90.4; 89.8 0.94
SECONDARY
Satisfaction With Decision Making Process
75.6; 76.8 1.00
SECONDARY
Ottawa Decision Regret Scale
11.5; 12.9 0.95
SECONDARY
Satisfaction With Life Scale
27.9; 22.9 0.006 sig
SECONDARY
Satisfaction With Life Scale
27.9; 22.9 0.006 sig
SECONDARY
Preparedness for Decision-Making Scale
86.9; 81.8 0.27
SECONDARY
Usability and Acceptability: Helped me Understand More About the Risks and Benefits of Treatment.
21; 0; 12; 0; 2; 0
SECONDARY
Shared Decision-Making (SDM-9)
87.5; 85.2 0.74
SECONDARY
Shared Decision-Making (SDM-9)
87.5; 85.2 0.74
SECONDARY
Number and Percentage of Participants Whose Control Preferences for Treatment Decision-Making Match From Baseline to 1-month Follow-up
14; 13
SECONDARY
Ability to Envision Life With an LVAD: Somewhat/Easy Picturing What to Expect
25; 25
SECONDARY
Number and Percentage of Participants Reporting Ability to Envision Life With an LVAD: Difficult/no Idea What to Expect
15; 9
SECONDARY
Number & Percentage of Participants Who Perceived a Strong Likelihood of Transplant
16; 22 0.60
SECONDARY
Number and Percentage of Participants Who Perceived and Strong Likelihood of Transplant
17; 15 0.27
SECONDARY
Participants' Perceived Survival Estimate in Number of Years After LVAD Implant
10.17; 9.7 0.45
SECONDARY
Satisfaction With Life
27.9; 22.9 0.006 sig
SECONDARY
Quality of Life -- Health Rating
81.0; 69.1 0.03 sig
SECONDARY
Quality of Life -- Health Rating
81.0; 69.1 0.03 sig
SECONDARY
Preferred Treatment: Number of Patients Predicting They Will Choose LVAD
28; 31
SECONDARY
Number of Patients Whose Preferred Treatment Was LVAD
22; 25 0.74
SECONDARY
Number of Patients Whose Preferred Treatment Was LVAD
22; 25 0.74
SECONDARY
Number and Percentage of Patients Who Filled Out an Advanced Directive
17; 12 0.12
SECONDARY
Usability and Acceptability: Helped me Understand my Options for Dealing With Heart Failure.
19; 0; 11; 0; 4; 0
SECONDARY
Usability and Acceptability: Learned Something New That I Didn't Know Before.
20; 0; 9; 0; 5; 0
SECONDARY
Usability and Acceptability: Would Recommend to Others.
34; 0; 3; 0; 0; 0
SECONDARY
Usability and Acceptability: Held my Interest.
34; 0; 2; 0; 1; 0
SECONDARY
Usability and Acceptability: Helps Someone Make an Informed Decision.
33; 0; 2; 0; 0; 0
SECONDARY
Usability and Acceptability: Helped me to Think About Aspects of Heart Failure Treatment That Matter Most to me.
30; 0; 4; 0; 1; 0
SECONDARY
Participants' Control Preferences Over Treatment Decision-Making
3; 1; 10; 18; 10; 8 0.20
SECONDARY
Participants' Control Preferences Over Treatment Decision-Making
3; 1; 10; 18; 10; 8 0.20

Summary

The goal of this project is to develop a patient-centered decision aid for decision-making about end-stage heart failure treatment. This study seeks to create a decision aid that presents outcomes, risks, projected experiences, and uncertainties about Left Ventricular Assist Device (LVAD) placement to help patients make values-based decisions about placement. The investigators propose a mixed methods design involving a literature search of clinical evidence, semi-structured patient interviews, and quantitative data from a multi-site trial of patients receiving the decision aid compared to patients not receiving the aid.

Eligibility Criteria

Inclusion Criteria

  • LVAD Candidates (NYHA Class III and IV patients with an acceptable surgical risk/benefit ratio for LVAD implantation and with good psychosocial support, coping mechanisms, and financial resources, as determined by "clearance" from the transplant social worker)
  • LVAD Patients
  • LVAD Decliners
  • LVAD Caregivers

Exclusion Criteria

  • subjects who lack the capacity to give informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02248974). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search